China Infrastructure Construction Corp.

Recent News

  • CHNC Publishes Its Phytotherapy Project With Cannabinoids That Seeks to Attack the Effects of COVID-19

    Houston, Texas--(Newsfile Corp. - November 18, 2020) - CHNC (OTC Pink: CHNC) Phytotherapy therapeutic program, comprised of cannabinoid molecule formulations, has the advantage of not having adverse effects and was developed to treat each of the three stages of COVID-19; from moderate, to the critical curse, and for the final leg of persistent inflammation, immunosuppression and catabolism syndrome.Cannot view this video? Visit: with the race and stru

    2020-11-18 8:15 AM ET